欧盟委员会发布《2025年欧盟工业研发投资记分牌》(2025 EU Industrial R&D Investment Scoreboard)，首次进入名单的亚马逊公 司位列榜首，2024会计年度共投入653亿欧元研发经费。排名前十的还有谷歌母公司ALPHABET、脸书母公司META、微软、苹 果、华为、三星电子、大众汽车、强生和英特尔。 本项调查面向全球2024会计年度研发投资额最多的2000家企业开展，这些企业的研发投资总额为14462亿欧元。美国、中国、欧 盟、日本的上榜公司数量名列前茅。排名前50位的公司研发投入6330亿欧元，占总研发投入的44%。 排名 公司 总部所在地 行业 研发投入/净销售额/研发占比 1、亚马逊(AMAZON.COM, INC.) 美国 软件和计算机服务 653.18亿欧元/6140.72亿欧元/10.64% 2、ALPHABET INC.(谷歌母公司) 美国 软件和计算机服务 461.31亿欧元/3369.12亿欧元/13.69% 3、META PLATFORMS, INC.(脸书母公司) 美国 软件和计算机服务 419.86亿欧元/1583.42亿欧元/26.52% 4、 ...

分组1 - The S&P 500 has shown resilience after flirting with bear market territory earlier this year, making healthcare stocks a strong consideration for potential investment in a bear market [1] - The healthcare sector is characterized by companies that tend to perform well during both economic upturns and downturns, with Johnson & Johnson and Abbott Laboratories highlighted as excellent stocks to buy in a bear market [2] 分组2 - Johnson & Johnson is a diversified healthcare leader with a strong presence in pharmaceuticals and medical technology, generating consistent revenue and profits even in weak economic conditions [4][5] - The company holds the highest credit rating, indicating financial stability, and is recognized as a Dividend King with 63 consecutive years of dividend increases, showcasing its ability to maintain payouts through various economic cycles [6] - Abbott Laboratories also exhibits strong diversification across medical devices, nutrition, diagnostics, and pharmaceuticals, allowing it to navigate challenging times effectively [7] - Abbott's growth prospects are particularly promising in diabetes care, with its FreeStyle Libre continuous glucose monitoring devices driving significant growth, and recent acquisitions aimed at expanding into the cancer diagnostic market [8]

Core Insights - The "High Income DIY Portfolios" service aims to provide high income with low risk and capital preservation for DIY investors, particularly targeting income investors such as retirees [1] - The service offers a total of 10 model portfolios, including various strategies for income generation and risk management, with a focus on sustainable yields [2] Group 1: Portfolio Strategies - The service includes seven portfolios: three buy-and-hold, three rotational portfolios, and a conservative NPP strategy portfolio designed for low drawdowns and high growth [1] - The investment approach emphasizes dividend-growing stocks and aims for a 30% reduction in drawdowns while targeting a 6% current income [2] Group 2: Additional Features - The service provides buy and sell alerts, live chat, and strategies for portfolio management and asset allocation to help investors achieve stable, long-term passive income [2]

Core Insights - Dividend growth stocks have historically provided strong returns, with an average annualized total return of 10.2% over the past 50 years, outperforming non-dividend payers and those with unchanged dividends [2] Group 1: NextEra Energy - NextEra Energy has increased its dividend for over 30 consecutive years, achieving a 10% compound annual growth rate over the past two decades, resulting in a 14% average annual total shareholder return [5][6] - The company expects to grow its adjusted earnings per share by more than 8% annually over the next decade and plans a 10% dividend increase in 2026, with a 6% compound annual growth rate through at least 2028 [8] Group 2: Realty Income - Realty Income has raised its dividend every year since its IPO in 1994, achieving a 4.2% compound annual growth rate and delivering a 13.7% average annualized total return [9] - The REIT invests in a diversified portfolio of properties secured by long-term net leases, producing durable rental income and maintaining a strong balance sheet [11][12] Group 3: Johnson & Johnson - Johnson & Johnson has increased its dividend for 63 consecutive years, qualifying as a Dividend King, and has delivered a 10.5% annualized total return over the past 30 years [13] - The company generates significant free cash flow, covering its dividend outlay, and invests heavily in research and development, supporting continued dividend growth [15][16] Group 4: Investment Potential - NextEra Energy, Realty Income, and Johnson & Johnson are positioned to continue their trends of dividend growth and double-digit annual total returns, making them ideal for investors looking to build a substantial portfolio [17]

The Dow Jones Industrial Average hit record all-time highs in 2025 with many of the components ending the year higher. Along with serving as a well-known barometer of overall market health, the index offers some of the top yielding blue-chip stocks.Here's a look at the top-yielding Dow Jones stocks heading into 2026.Top Yielding Dow Jones Industrial Average StocksWhen looking for dividend stocks, the Dow Jones Industrial Average has plenty of names to offer. Of the 30 components of the index, 28 currently p ...

Core Insights - The Dow Jones Industrial Average reached new all-time records in 2025, with President Donald Trump celebrating this achievement [1] Group 1: 2025 Performance Overview - In 2025, 23 out of 30 Dow Jones Industrial component stocks experienced gains, while 7 declined, marking an improvement compared to previous years where 18 stocks were up in 2024 and 19 in 2023 [2] - The overall performance of the Dow Jones Industrial Average was an increase of approximately 13% for the full year [3] Group 2: Top Gainers and Losers - The top five gainers in 2025 included: 1. Caterpillar: +59.5% 2. Goldman Sachs: +55.8% 3. Johnson & Johnson: +43.5% 4. NVIDIA: +40.2% 5. IBM: +39.1% [6] - The top five losers in 2025 included: 1. UnitedHealth Group: -35.0% 2. Salesforce: -20.4% 3. Nike: -19.1% 4. Procter & Gamble: -13.8% 5. Honeywell: -12.7% [6] Group 3: New Additions to the Index - Nvidia replaced Intel in the Dow Jones Industrial Average in November 2024, with Intel outperforming Nvidia in 2025, gaining over 90% [4] - Sherwin-Williams replaced Dow Inc. in November 2024, with Sherwin-Williams down 1.3% over the past year, while Dow stock fell more than 30% [5] - Amazon replaced Walgreens Boots Alliance, with Amazon shares up 4.8% in 2025 [6]

本文源自：金融界AI电报 强生(JNJ.N)宣布2026年第一季度股息为每股1.30美元，与前次常规现金股息持平。 ...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2026 of $1.30 per share on the company's common stock. The dividend is payable on March 10, 2026 to shareholders of record at the close of business on February 24, 2026. The ex-dividend date is February 24, 2026. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare in. ...

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Johnson & Johnson (JNJ), and emphasizes the importance of using these recommendations in conjunction with other analytical tools like the Zacks Rank for making informed investment decisions [1][5]. Brokerage Recommendations for Johnson & Johnson - Johnson & Johnson has an average brokerage recommendation (ABR) of 1.85, indicating a consensus between Strong Buy and Buy, based on 26 brokerage firms [2]. - Out of the 26 recommendations, 14 are classified as Strong Buy and 2 as Buy, representing 53.9% and 7.7% of total recommendations respectively [2]. Limitations of Brokerage Recommendations - Solely relying on brokerage recommendations may not be advisable, as studies indicate they often fail to guide investors effectively towards stocks with high potential for price appreciation [5]. - Analysts from brokerage firms tend to exhibit a positive bias in their ratings due to vested interests, issuing five "Strong Buy" recommendations for every "Strong Sell" [6][11]. Zacks Rank as an Alternative Indicator - The Zacks Rank, which categorizes stocks from 1 (Strong Buy) to 5 (Strong Sell), is presented as a more reliable indicator of near-term price performance, driven by earnings estimate revisions [8][12]. - Unlike the ABR, the Zacks Rank is timely and reflects the latest earnings estimates, making it a more effective tool for predicting stock price movements [13]. Current Earnings Estimates for Johnson & Johnson - The Zacks Consensus Estimate for Johnson & Johnson's current year earnings has remained stable at $10.87 over the past month, indicating analysts' optimism regarding the company's earnings prospects [14]. - The Zacks Rank for Johnson & Johnson is currently 2 (Buy), influenced by the recent changes in consensus estimates and other related factors [15].

Core Insights - The article discusses the author's background in analytics and accounting, highlighting over 10 years of experience in the investment sector, progressing from an analyst to a management role [1]. Group 1 - The author holds a master's degree in Analytics from Northwestern University and a bachelor's degree in Accounting [1]. - The author has a personal interest in dividend investing and aims to share insights with the Seeking Alpha community [1]. Group 2 - The author has disclosed a beneficial long position in several companies, including ABBV, ADP, HRL, JNJ, LOW, PEP, and SPGI, through various investment vehicles [2]. - The article expresses the author's personal opinions and is not influenced by compensation from any company mentioned [2].